SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Month: May 2019

    Summary of Research and Developments-2019

    Posted on May 25, 2019April 2, 2022 by Dan Roberts
  • May 25, 2019

    Summary of Research and Developments-2019

    This is our 14th annual summary presented to the International Low Vision Support Group about leading research and developments during the past 12 months in the fields of blindness and low vision. Most activity has been in the fields of anti-VEGF treatment and gene replacement therapy. We have also seen promising work with stem cell […]

      Also posted in
    • Latest News
    • Research and Developments
  • Why Do More Women Than Men Have AMD?

    Posted on May 19, 2019 by Dan Roberts
  • May 19, 2019

    Why Do More Women Than Men Have AMD?

    Nearly every reliable resource on age-related macular degeneration (AMD) will reveal that more women than men are affected by the disease. Some even go so far as to offer questionable statistics like “About 2/3 of people with AMD are women and 1/3 men”.(1) To explain, writers offer that women live longer than men, or that […]

      Also posted in
    • Latest News
    • Research and Developments
  • Eylea Approved for Diabetic Retinopathy Treatment

    Posted on May 14, 2019 by Dan Roberts
  • May 14, 2019

    Eylea Approved for Diabetic Retinopathy Treatment

    Regeneron Pharmaceuticals, Inc. has announced FDA approval of Eylea (aflibercept) injection to treat all stages of diabetic retinopathy. Eylea is already approved for treatment of three conditions: neovascular (wet) age-related macular degeneration, macular edema resulting from retinal vein occlusion, and diabetic macular edema.  This additional use of Eylea for diabetic retinopathy was approved based upon […]

      Also posted in
    • Latest News
    • Research and Developments
  • Need For Improvement in Hospital Care For Vision-Impaired Patients

    Posted on May 13, 2019 by Dan Roberts
  • May 13, 2019

    Need For Improvement in Hospital Care For Vision-Impaired Patients

    Recent research spotlights a need to address certain risks and incapacities with which people with visual impairment are faced during hospital stays. Vision-impaired hospital patients have worse clinical outcomes, more readmissions, longer lengths of stay, and higher costs of care than non-vision-impaired patients, according to the authors. The article, published April 4, 2019 in JAMA […]

      Also posted in
    • Latest News
    • Research and Developments
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.